(MedPage Today) -- Monitoring committee suggests that CANVAS trial continue
via FDA: Canagliflozin Linked to Amputations in Post-Marketing Trial
by
Showing posts with label FDA: Canagliflozin Linked to Amputations in Post-Marketing Trial. Show all posts
Showing posts with label FDA: Canagliflozin Linked to Amputations in Post-Marketing Trial. Show all posts
Wednesday, May 18, 2016
Subscribe to:
Posts (Atom)